Nazgul Omarbayeva

Nazgul Omarbayeva

Auto-generated profile, based on publicly available information

Nazgul Omarbayeva

Kazakh Institute of Oncology and Radiology

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2024 in Tumors of female reproductive system
Verified
Journal Article
Open access
PDF file
NON. A. Omarbayeva
N. A. Omarbayeva
Dilyara KaidarovaDilyara Kaidarova
Dilyara Kaidarova
DOD. Kh. Omarov
D. Kh. Omarov
AAA. Askandirova
A. Askandirova
KKKh. Keskin
Kh. Keskin
AJA. K. Jakipbayeva
A. K. Jakipbayeva
Background. Oncologists notice an increasing prevalence of female reproductive system pathological conditions that lead to benign and malignant diseases of mammary glands. Fibrocystic breast diseases (FBD) occur in approximately 80 % of women of reproductive age worldwide. Currently, there is no single widely accepted treatment for FBD. The therapy mainly includes surgery and hormonal treatment. A few herbal medicines effective against FBD include Vitex agnus-castus (VAC) medications. According to many studies, the absence of timely targeted preventive therapy puts patients with FBD at risk of developing malignant tumors. FBD is a risk factor for cancer development and turns into cancer in 3–6 % of patients.Aim. To assess the effectiveness of VAC against FBD.Materials and methods. In this study, 150 women aged 40+ with FBD were randomly assigned to the treatment group (n = 78) or the controls (n = 72). The groups were similar in demographic characteristics, including age, parity, menopause, history of abortions, family history of breast cancer, and alcohol and tobacco consumption. The treatment group received two tablets of VAC extract (each containing 162 mg) daily for six months. At baseline, weeks 12 and 24, all participants were evaluated using a visual analog scale and ultrasound examination.Results. Breast pain decreased significantly in the treatment group, and the median visual analog scale scores at weeks 12 and 24 decreased significantly compared to baseline in the treatment group (89.7 % at baseline, 76.9 % at week 12, and 42.3 % at week 24) compared to the controls (66.3 % at baseline, 63.9 % at week 12 and 61.1 % at week 24). Furthermore, the breast ultrasound findings at weeks 12 and 24 revealed that regression rates in the treatment group were significantly higher than in the control arm (46.2 % vs. 6.9 % at week 12; 55.1 % vs. 8.3 % at week 24).Conclusion. VAC is effective in managing patients with FBD. VAC treatment efficacy can be evaluated using a visual analog scale and ultrasound examination. The herbal remedy VAC extract used in this treatment for patients with FBD has proven effective in preventing breast cancer.

30 September 2023 in Oncologia i Radiologia Kazakhstana
Verified
Journal Article
Closed access
Dilyara KaidarovaDilyara Kaidarova
Dilyara Kaidarova
NON. Omarbayeva
N. Omarbayeva
DOD. Omarov
D. Omarov
AAA. Abdrakhmanova
A. Abdrakhmanova
KSK. Smagulova
K. Smagulova
TGTatyana Goncharova
Tatyana Goncharova
Relevance: Breast cancer (BC) is one of the major health problems in the Republic of Kazakhstan. Genome-wide association studies (GWAS) are used to identify genetic factors contributing to breast cancer development in Kazakhstan and worldwide. The GWAS method consistently helps to find associations between certain single nucleotide polymorphisms (SNPs) in the genome and the development of pathological conditions, including breast cancer, by identifying more than 170 genomic sites. In addition to searching for loci associated with BC, these studies have expanded our understanding of BC heritability using SNPs located in regulatory areas and identifying DNA variants associated with drug metabolism for treatment personalization purposes. The study aimed to highlight the key concepts of modern methods in genetics based on GWAS. Methods: A literature search in PubMed, Scopus, GWAS Catalog, Cochrane Database of Systematic Reviews, etc., was performed to select and analyze relevant information Results: The article describes significant GWAS studies in the field of breast cancer, describes certain genes associated with the development of the disease, identifies shortcomings, and identifies further strategies for the development of GWAS in the Republic of Kazakhstan Conclusion: The results of this study have improved our understanding of the biological mechanisms that contribute to breast cancer risk and may ultimately lead to the development of new targeted therapies for the disease

5 August 2026 in Exploration of Targeted Anti-tumor Therapy
Verified
Journal Article
Open access
PDF file
Dilyara KaidarovaDilyara Kaidarova
Dilyara Kaidarova
IOIndira Omarova
Indira Omarova
SKSamat Kaldarbekov
Samat Kaldarbekov
NONazgul Omarbayeva
Nazgul Omarbayeva
MDMaia Dzhugashvili
Maia Dzhugashvili
TMTimur Mitin
Timur Mitin
Aim: Oligoprogressive disease (OPD) has emerged as a clinically relevant and common scenario in oncology, reflecting progression in a limited number of metastatic sites while systemic therapy continues to control the majority of disease. Despite its increasing recognition, the definition, diagnostic approach, and management of OPD remain poorly standardized. Methods: A multidisciplinary expert panel from Kazakhstan and international faculty, including ten medical oncologists, radiation, and surgical oncologists, participated in a structured survey. The questionnaire consisted of 15 items divided into three domains: definition of OPD, diagnostic evaluation, and treatment strategies. Responses were analyzed, and consensus was defined as ≥ 70% agreement, relative agreement as 50–69%, and lack of consensus as < 50%. Results: Consensus was reached that OPD is defined as progression in a limited number of lesions while other sites remain controlled, regardless of lesion size or localization. No consensus was achieved regarding the maximum number of progressive lesions, with experts divided between “≤ 5 lesions” and “any number amenable to local therapy.” Imaging with CT or PET-CT was considered sufficient. Biopsy and molecular testing were recommended only in selected contexts. Systemic therapy continuation during OPD was endorsed if effective, with strong support for local therapy, particularly stereotactic ablative radiotherapy (SBRT/SABR). Divergence remained regarding the management of repeat OPD. Conclusions: This Kazakhstan Cancer Society consensus defines the fundamental clinical features of OPD and provides practical recommendations for diagnosis and treatment. Comparison with international guidelines reveals broad alignment on systemic continuation and local therapy, as well as persistent variation regarding lesion number, biopsy, and repeat OPD management.

10 October 2023 in Oncologia i Radiologia Kazakhstana
Verified
Journal Article
Closed access
Dilyara KaidarovaDilyara Kaidarova
Dilyara Kaidarova
NON. Omarbayeva
N. Omarbayeva
DOD. Omarov
D. Omarov
AAA. Abdrakhmanova
A. Abdrakhmanova
KSK. Smagulova
K. Smagulova
TGTatyana Goncharova
Tatyana Goncharova
Relevance: Breast cancer (BC) is one of the major health problems in the Republic of Kazakhstan. Genome-wide association studies (GWAS) are used to identify genetic factors contributing to breast cancer development in Kazakhstan and worldwide. The GWAS method consistently helps to find associations between certain single nucleotide polymorphisms (SNPs) in the genome and the development of pathological conditions, including breast cancer, by identifying more than 170 genomic sites. In addition to searching for loci associated with BC, these studies have expanded our understanding of BC heritability using SNPs located in regulatory areas and identifying DNA variants associated with drug metabolism for treatment personalization purposes. The study aimed to highlight the key concepts of modern methods in genetics based on GWAS. Methods: A literature search in PubMed, Scopus, GWAS Catalog, Cochrane Database of Systematic Reviews, etc., was performed to select and analyze relevant information. Results: The article describes significant GWAS studies in the field of breast cancer, describes certain genes associated with the development of the disease, identifies shortcomings, and identifies further strategies for the development of GWAS in the Republic of Kazakhstan. Conclusion: The results of this study have improved our understanding of the biological mechanisms that contribute to breast cancer risk and may ultimately lead to the development of new targeted therapies for the disease.

12 November 2025 in Oncologia i Radiologia Kazakhstana
Verified
Journal Article
Open access
PDF file
NNN.M. Nurgaliyeva
N.M. Nurgaliyeva
SKS.A. Kan
S.A. Kan
ATA.M. Tolendiyeva
A.M. Tolendiyeva
NON.A. Omarbayeva
N.A. Omarbayeva
YOYekaterina Ostapchuk
Yekaterina Ostapchuk
EOE.O. Ostapchuk
E.O. Ostapchuk
Relevance: Hepatocellular carcinoma (HCC) is one of the most aggressive and deadly malignant tumors, characterized by treatment complexity and high resistance to immunotherapy. Alpha-fetoprotein (AFP) is traditionally used as a diagnostic marker for HCC. Recent studies reveal its key role in carcinogenesis and in forming a tolerogenic microenvironment that suppresses the anti-tumor immune response. Despite numerous publications, contradictions remain in assessing AFP’s functions and prognostic value, necessitating an analytical review. This study aimed to summarize current data on AFP’s role in tumor immune evasion mechanisms and to evaluate its potential as a target for novel immunotherapeutic approaches for HCC treatment. Methods: A systematic search and analysis of publications on AFP and HCC were conducted in PubMed and Google Scholar, and several specialized medical and scientific journals (including Cancer Research) from 2017 to 2025. Keywords included: “alpha-fetoprotein”, “hepatocellular carcinoma”, “immunosuppression”, “tumor immune evasion”, “AFP immunomodulation”, “immune response in HCC”. Selected articles met relevance and novelty criteria. Results: The review revealed that AFP plays a central role in HCC progression through its immunosuppressive effects and activation of tumor immune evasion mechanisms. Contradictions in prognostic data reflect the complexity and multilayered biological functions of AFP. Conclusion: AFP is not only a key diagnostic marker for HCC but also plays an active role in establishing immune tolerance. Its ability to suppress antitumor immune response makes AFP a promising therapeutic target, especially in combined immunotherapeutic approaches aiming to improve treatment efficacy.

12 November 2025 in Oncologia i Radiologia Kazakhstana
Verified
Journal Article
Open access
PDF file
NNN. Nurgaliyeva
N. Nurgaliyeva
СКС.а. Кан
С.а. Кан
ATA. Tolendiyeva
A. Tolendiyeva
NON. Omarbayeva
N. Omarbayeva
YOYekaterina Ostapchuk
Yekaterina Ostapchuk
YOYekaterina Ostapchuk
Yekaterina Ostapchuk
Relevance: Hepatocellular carcinoma (HCC) is one of the most aggressive and deadly malignant tumors, characterized by treatment complexity and high resistance to immunotherapy. Alpha-fetoprotein (AFP) is traditionally used as a diagnostic marker for HCC. Recent studies reveal its key role in carcinogenesis and in forming a tolerogenic microenvironment that suppresses the anti-tumor immune response. Despite numerous publications, contradictions remain in assessing AFP’s functions and prognostic value, necessitating an analytical review. This study aimed to summarize current data on AFP’s role in tumor immune evasion mechanisms and to evaluate its potential as a target for novel immunotherapeutic approaches for HCC treatment. Methods: A systematic search and analysis of publications on AFP and HCC were conducted in PubMed and Google Scholar, and several specialized medical and scientific journals (including Cancer Research) from 2017 to 2025. Keywords included: “alpha-fetoprotein”, “hepatocellular carcinoma”, “immunosuppression”, “tumor immune evasion”, “AFP immunomodulation”, “immune response in HCC”. Selected articles met relevance and novelty criteria. Results: The review revealed that AFP plays a central role in HCC progression through its immunosuppressive effects and activation of tumor immune evasion mechanisms. Contradictions in prognostic data reflect the complexity and multilayered biological functions of AFP. Conclusion: AFP is not only a key diagnostic marker for HCC but also plays an active role in establishing immune tolerance. Its ability to suppress antitumor immune response makes AFP a promising therapeutic target, especially in combined immunotherapeutic approaches aiming to improve treatment efficacy.